Maravai Lifesciences Holdings (MRVI) Non-Current Debt (2020 - 2026)

Maravai Lifesciences Holdings' Non-Current Debt history runs 7 years deep, the most recent figure standing at $235.6 million for Q1 2026.

• In Q1 2026, Non-Current Debt fell 18.63% year-over-year to $235.6 million; the TTM figure through Mar 2026 stood at $235.6 million (down 18.63% YoY), while the FY2025 annual figure was $286.3 million, down 1.43% from the prior year.
• Non-Current Debt was $235.6 million for Q1 2026 at Maravai Lifesciences Holdings, down from $286.3 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $711.2 million in Q3 2022 to a low of $235.6 million in Q1 2026.
• Historically, Non-Current Debt has averaged $455.7 million across 5 years, with a median of $517.9 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Non-Current Debt soared 37.17% in 2022, then tumbled 44.34% in 2025.
• A 5-year view of Non-Current Debt shows it stood at $522.0 million in 2022, then fell by 0.63% to $518.7 million in 2023, then tumbled by 44.0% to $290.5 million in 2024, then declined by 1.43% to $286.3 million in 2025, then retreated by 17.73% to $235.6 million in 2026.
• The last three Non-Current Debt figures came in at $235.6 million (Q1 2026), $286.3 million (Q4 2025), and $287.4 million (Q3 2025), per Business Quant data.